Organogenesis: Need of the Current World
Starfish regrow arms. Salamanders replace limbs. Flatworms even regenerate heads. But for humans—who can’t regrow a finger, let alone an organ—this kind of regeneration has long been a fantasy. Today, though, a field called organogenesis is turning that fantasy into reality. By growing human-like organs (called “organoids”) in labs using stem cells and developmental biology, scientists are solving some of medicine’s biggest challenges: infertility, organ failure, neurological disorders, and more. This article draws on research by Arsalan Ahmad, Hafiz Muhammad Umer Aslam (University of Management & Technology and University of the Punjab, Pakistan), Muhammad Sohail Afzal (University of Management & Technology), and Zubair Bhutta (Mayo Hospital, Lahore), published in the Chinese Medical Journal in 2019.
Organogenesis isn’t about creating full-sized organs for transplant—yet. Instead, it’s about building 3D “mini organs” that mimic the structure, function, and genetics of real human tissue. These organoids let scientists study diseases in human cells (not just mice), test drugs safely, and even grow patient-matched tissues for repair. And while the field is young, its impact is already being felt.
Why Organogenesis Matters
Every year, 120,000 people in the U.S. wait for an organ transplant—and 17 die daily waiting (Organ Procurement and Transplantation Network). Globally, kidney disease affects 850 million people, liver failure kills 1 million yearly, and RSV (a respiratory virus) takes 250,000 children’s lives (World Health Organization, WHO). Organoids offer a way to address these crises without relying on donor organs or animal models that don’t fully reflect human biology.
But organogenesis isn’t without ethical questions. Growing human-like tissues raises concerns about consent, embryo use, and where to draw the line between research and human creation. As noted in a 2009 Endocrine Reviews study, scientists and policymakers are working to balance innovation with responsibility—ensuring progress stays grounded in ethics.
Lab-Grown Organs Changing Medicine
Let’s look at some of the most promising breakthroughs:
Fallopian Tubes: Fixing Fertility
Fallopian tubes are critical for fertility—they carry eggs from ovaries to the uterus. When damaged, pregnancy can be impossible. In 2015, scientists at Berlin’s Max Planck Institute for Infection Biology grew the first fallopian tube organoids using donor epithelial cells. They identified two key signaling pathways (Notch and Wnt) that drive organ development, creating structures nearly identical to real tubes in size and shape. This Nature Communications study could help treat tubal infertility and study diseases like ectopic pregnancy.
Mini Brains: Unlocking Neurological Mysteries
The human brain is one of the most complex organs to study—until now. Researchers at Ohio State University grew a “mini brain” the size of a pencil eraser, genetically and structurally matching a 5-week-old fetal brain. It has functioning neurons with dendrites (signal receivers) and axons (signal senders). Before organoids, scientists relied on rodents to study Alzheimer’s, autism, and Parkinson’s—but rodent brains aren’t human. This 2013 Science study lets researchers directly observe how the human brain develops and responds to drugs.
Mini Hearts: Regenerating After Heart Attacks
Heart attacks damage muscle cells that can’t regrow—until now. In 2015, scientists created the first 3D “mini heart” from stem cells, measuring just half a millimeter across. Using this model, they discovered that young human heart cells can regenerate after injury—a game-changer for treating heart disease (the #1 killer globally). Published in Nature Communications, this research could lead to therapies that repair damaged hearts without transplants.
Mini Kidneys: Fighting Renal Failure
Kidney disease is a silent epidemic—8% of cases grow more severe yearly (2008 data), and end-stage care costs $39 billion annually in the U.S. The University of Queensland’s mini kidneys are a breakthrough: they have all the cell types of a mature kidney and develop just like human fetal kidneys. These organoids are already used for drug screening (testing if new meds harm kidneys) and disease modeling (studying polycystic kidney disease). As noted in a 2011 Organogenesis study, they could even lead to regenerating damaged kidneys in patients.
Mini Lungs: Beating RSV and Beyond
RSV kills 250,000 children yearly by damaging lungs. Columbia University’s mini lungs—grown from pluripotent stem cells (cells that can turn into almost any cell type)—look, work, and react like real human lungs. When researchers infected them with RSV, the organoids developed the disease just like humans—letting scientists study the virus faster than ever. This 2017 Nature Cell Biology study could speed up RSV vaccine development and help treat other lung diseases, from asthma to COPD.
Mini Stomachs: Stopping Gastric Cancer
Gastric cancer is the 3rd leading cause of cancer death globally, and 25% of Americans have stomach issues yearly. Cincinnati Children’s Hospital grew a 0.1-inch mini stomach from pluripotent stem cells, mimicking the fetal stomach’s lining and development. For the first time, scientists can watch how the stomach forms and how bacteria (like H. pylori, which causes ulcers) attack it. Published in Nature in 2014, this model could improve drug testing for ulcers and cancer—and maybe even lead to stomach tissue transplants.
Vaginas: Restoring Function for MRKH Patients
Mayer-Rokitansky-Küter-Hauser (MRKH) syndrome affects 1 in 1,500 girls—their vagina and uterus don’t develop fully, often causing infertility and shame. In 2014, scientists at the Autonomous University of Nuevo León (Mexico) grew vaginal organs using patients’ own vulvar cells: they cultured epithelial and muscle cells on a biodegradable scaffold, then implanted it. Four teens (13–18 years old) received transplants, and after 8 years, all reported normal sexual function—including desire, lubrication, and painless intercourse. This Lancet study is a landmark for personalized organ transplants, showing that patient-matched tissues can eliminate rejection.
Penises: Helping Veterans and Cancer Survivors
War trauma and penile cancer often leave men with life-altering disfigurement. Current options—using skin from the thigh or forearm, or donor transplants—have high rejection rates. But Wake Forest Institute for Regenerative Medicine grew functional penile tissue in rabbits, which successfully mated after transplant. The goal? Grow penises using a patient’s own cells to avoid rejection. Funded by the U.S. Armed Forces Institute of Regenerative Medicine, this research offers hope for restoring both physical and psychological health.
Esophagus: Fixing Swallowing Problems
Esophageal cancer kills 500,000 people yearly, and surgeries to replace damaged esophagus with intestine often leave patients unable to swallow solids. Karolinska Institutet (Sweden) grew a lab esophagus using stem cells on a scaffold, then transplanted it into rats—replacing 20% of their esophagus. The organ developed muscle cells, nerve connections, and blood vessels, working both voluntarily (swallowing) and involuntarily. This 2018 Nature Communications study could soon help human patients eat normally again.
Ears: Restoring Hearing and Balance
5.3% of the world’s population has middle ear injuries, leading to hearing loss or balance issues (WHO, 2012). Indiana University School of Medicine grew 3D inner ear organoids from stem cells, guiding them through human ear development. These organoids have sensory and supporting cells just like real ears—and when implanted on rats’ backs, they grew for 3 months. This 2016 PLOS One study could help children with congenital ear deformities and adults who lost ears to trauma or cancer.
Liver Cells: Treating Liver Failure
The liver detoxifies the body, makes proteins, and regulates metabolism—but growing liver cells outside the body is hard. In 2015, German and Israeli scientists grew 3D liver organoids from stem and progenitor cells. These spherical structures preserve key liver functions (detoxification, protein synthesis) and can be made from adult liver cells or pluripotent stem cells. Published in Nature Protocols, this research could lead to autologous liver cell therapy—using a patient’s own cells to repair liver damage, reducing transplant rejection.
The Future of Organogenesis
Organogenesis isn’t just about growing organs—it’s about reimagining how we treat disease. Instead of waiting for a donor organ (which only 3 in 10,000 people receive), patients could get lab-grown tissues made from their own cells. Instead of testing drugs on animals (which fail 90% of the time in human trials), scientists could use organoids to predict how humans will react. And instead of accepting that some diseases are “incurable,” we could fix them at the cellular level.
The road ahead has challenges: organoids are still small (limited by nutrient and oxygen access in labs), and growing full-sized organs will require solving vascularization (getting blood vessels to feed the tissue). But the progress in just a decade is stunning. As researchers refine techniques, collaborate across fields, and address ethics, organogenesis could become the backbone of 21st-century medicine.
For a world where millions wait for transplants, where diseases like Alzheimer’s and RSV still kill, and where organ failure ruins lives—organogenesis isn’t just a “need”—it’s a lifeline.
Ahmad A, Umer Aslam HM, Afzal MS, Bhutta Z. Organogenesis: need of the current world. Chin Med J 2019;132:849–852.
doi.org/10.1097/CM9.0000000000000048
Was this helpful?
0 / 0